Shares of AbbVie Inc. rose 3.38% to $192.34 Monday, on what proved to be an all-around great trading session for the stock ...

Shares of AbbVie Inc. ABBV advanced 1.88% to $180.37 Thursday, on what proved to be an all-around favorable trading session ...

AbbVie (ABBV) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...

We recently published a list of Billionaire Ken Fisher’s 10 Healthcare Stock Picks with Massive Upside Potential. In this ...

AbbVie Inc (ABBV) surpasses expectations with robust sales growth in Skyrizi and Rinvoq, while navigating challenges in ...

AbbVie Inc. beat revenue & EPS estimates, raised guidance due to Skyrizi & Rinvoq growth. Immunology shines; future ...

Jeffrey Stewart; Executive Vice President, Chief Commercial Officer; AbbVie Inc Roopal Thakkar; Executive Vice President, Research & Development, Chief Scientific Officer; AbbVie Inc Scott Reents ...

AbbVie Inc. raised its profit outlook for the year on better-than-expected sales from newer autoimmune treatments.

AbbVie stock climbs after Q1 earnings beat and 2025 EPS forecast raise; strong growth in immunology and neuroscience ...

NORTH CHICAGO, Ill. (AP) — NORTH CHICAGO, Ill. (AP) — AbbVie Inc. (ABBV) on Friday reported first-quarter profit of $1.29 billion. The North Chicago, Illinois-based company said it had net income of ...

Jeffrey Stewart; Executive Vice President, Chief Commercial Officer; AbbVie Inc Roopal Thakkar; Executive Vice President, Research & Development, Chief Scientific Officer; AbbVie Inc Scott Reents; ...